Recent Posts
- More Sensitive Cell Therapy May Be a HIT Against Solid Cancers
- Seattle jury awards $24M in lawsuit against stem cell center
- After gene therapy exit, Pfizer locks in global license for Beam gene editing candidate
- Phase I/II study finds intravitreal CD34+ stem cells safe and feasible in CRVO
- New Bio-Implant for Spinal Cord Repair